We are live on
!
Find out more
SCM
Sterling Capital Management Portfolio holdings
AUM
$5.9B
1-Year Est. Return
29.63%
This Fund
S&P 500
This Quarter
Est. Return
-1.56%
1 Year Est. Return
+29.63%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.45B
AUM Growth
-$851M
(-12%)
Cap. Flow
-$617M
Cap. Flow
% of AUM
-9.57%
Top 10 Holdings %
Top 10 Hldgs %
23.85%
Holding
3,274
New
30
Increased
484
Reduced
2,296
Closed
55
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$102M |
| 2 |
Accenture
ACN
|
+$72.7M |
| 3 |
Rockwell Automation
ROK
|
+$41.1M |
| 4 |
Booz Allen Hamilton
BAH
|
+$27.4M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$13.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Raymond James Financial
RJF
|
+$97M |
| 2 |
Hershey
HSY
|
+$93.2M |
| 3 |
Microchip Technology
MCHP
|
+$92.3M |
| 4 |
Global Payments
GPN
|
+$29.9M |
| 5 |
Merck
MRK
|
+$29.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.55% |
| 2 | Financials | 17.86% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 9.07% |
| 5 | Consumer Discretionary | 8.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Theravance Biopharma
TBPH
$884M
| $5.73K | ﹤0.01% |
642
-534
| -45% | -$4.97K |
|
2027
Relay Therapeutics
RLAY
$4.13B
| $5.73K | ﹤0.01% |
2,186
-1,648
| -43% | -$6.46K |
|
2028
Tejon Ranch
TRC
$432M
| $5.72K | ﹤0.01% |
361
-309
| -46% | -$4.91K |
|
2029
America's Car Mart
CRMT
$15.1M
| $5.72K | ﹤0.01% |
126
-100
| -44% | -$4.68K |
|
2030
TG Therapeutics
TGTX
$8.55B
| $5.72K | ﹤0.01% |
145
+4
| +3% | +$135 |
|
2031
Village Super Market
VLGEA
$654M
| $5.7K | ﹤0.01% |
150
-129
| -46% | -$4.29K |
|
|
SFIX
2032
Stitch Fix
SFIX
$388M
| $5.68K | ﹤0.01% |
1,748
-1,443
| -45% | -$6.58K |
|
2033
Matrix Service
MTRX
$280M
| $5.67K | ﹤0.01% |
456
-392
| -46% | -$5.25K |
|
|
BCPC
2034
Balchem Corp
BCPC
$5.34B
| $5.64K | ﹤0.01% |
34
+1
| +3% | +$164 |
|
|
HOUS
2035
DELISTED
Anywhere Real Estate
HOUS
| $5.64K | ﹤0.01% |
1,693
-1,450
| -46% | -$5.14K |
|
2036
Bumble
BMBL
$396M
| $5.63K | ﹤0.01% |
1,297
-1,500
| -54% | -$9.77K |
|
2037
Geron
GERN
$829M
| $5.63K | ﹤0.01% |
3,540
-2,534
| -42% | -$6.17K |
|
2038
Preformed Line Products
PLPC
$1.94B
| $5.6K | ﹤0.01% |
40
-34
| -46% | -$4.62K |
|
|
VERV
2039
DELISTED
Verve Therapeutics
VERV
| $5.6K | ﹤0.01% |
1,226
-1,050
| -46% | -$7.03K |
|
2040
Herbalife
HLF
$1.24B
| $5.59K | ﹤0.01% |
648
-486
| -43% | -$3.46K |
|
|
LENZ
2041
LENZ Therapeutics
LENZ
$130M
| $5.58K | ﹤0.01% |
217
-185
| -46% | -$4.56K |
|
2042
Pacific Biosciences
PACB
$417M
| $5.57K | ﹤0.01% |
4,720
-4,042
| -46% | -$6.2K |
|
2043
Stride
LRN
$3.41B
| $5.57K | ﹤0.01% |
44
+1
| +2% | +$126 |
|
2044
American Public Education
APEI
$813M
| $5.56K | ﹤0.01% |
249
-213
| -46% | -$4.62K |
|
2045
Intrepid Potash
IPI
$514M
| $5.55K | ﹤0.01% |
189
-161
| -46% | -$4.25K |
|
2046
Claros Mortgage Trust
CMTG
$203M
| $5.55K | ﹤0.01% |
1,489
-1,276
| -46% | -$4.38K |
|
2047
West Bancorporation
WTBA
$502M
| $5.54K | ﹤0.01% |
278
-240
| -46% | -$5.13K |
|
2048
Compass Minerals
CMP
$1B
| $5.54K | ﹤0.01% |
596
-510
| -46% | -$5.82K |
|
2049
Granite Ridge Resources
GRNT
$653M
| $5.52K | ﹤0.01% |
908
-779
| -46% | -$4.82K |
|
2050
Alkermes
ALKS
$7.73B
| $5.51K | ﹤0.01% |
167
+4
| +2% | +$130 |
|
Similar funds
SM
DGI
GAM
CDDEC
AAS
DCP
SDIC
MSRPS
Sterling Capital Management's Q1 2025 Portfolio in Review
As of Q1 2025, Sterling Capital Management held 3,274 positions worth $6.45B, down 12% from $7.3B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Sterling Capital Management withdrew a net $617M in Q1 2025, closing 55 positions and reducing 2,296 holdings. Its most notable exit was WESCO International, Inc. Depositary Shares each representing 1/1,000th interest in a share of Series A Fixed-Rate Reset Cumulative Perpetual Preferred Stock, an estimated $4.77M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Sterling Capital Management opened a new position in Samsara worth $2.79M.
- Sterling Capital Management's largest Q1 2025 buy was Samsara: 72,827 shares worth $2.79M.
- Sterling Capital Management added most to Linde in Q1 2025, an estimated $102M increase.
- Sterling Capital Management's biggest Q1 2025 reduction was Raymond James Financial, cutting an estimated $97M.
- Sterling Capital Management fully exited WESCO International, Inc. Depositary Shares each representing 1/1,000th interest in a share of Series A Fixed-Rate Reset Cumulative Perpetual Preferred Stock in Q1 2025, selling an estimated $4.77M.
- Sterling Capital Management's ten largest holdings make up 24% of its $6.45B portfolio in Q1 2025.
- Sterling Capital Management opened 30 new positions and closed 55 in Q1 2025.
- Sterling Capital Management's portfolio value fell 12% quarter-over-quarter to $6.45B.
Based on Sterling Capital Management's 13F filing for Q1 2025, filed 13 May 2025.